Axium
Device Neuromodulation
PDI 05415067025500
General payments
$141,026
Research payments
$0
Through program year 2024, $141,026 in general payments and $0 in research payments were reported against Axium (Neuromodulation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $3,687 | 66 |
| 2023 | General | $13,336 | 296 |
| 2022 | General | $124,004 | 1,651 |
Breakdown
The top 5 of 50 recipients; each share is of general payments naming this product in 2024.
The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 18 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
2,013 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.